末梢血管デバイスの市場規模、シェア、成長分析：タイプ別、用途別、最終用途別、地域別 - 産業予測 2025～2032年

末梢血管デバイス市場規模は2023年に84億9,000万米ドルと評価され、2024年の89億6,000万米ドルから2032年には137億5,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは5.5%で成長する見通しです。

世界の末梢血管デバイス市場は、血管疾患の罹患率の上昇と高齢化によって大きな成長を遂げています。糖尿病や肥満などの生活習慣病の増加がこの動向に寄与し、革新的な治療ソリューションの需要を押し上げています。これらの機器は、血管形成術やステント留置術のような低侵襲介入を容易にし、患者の快適性を高め、回復時間を短縮します。画像技術の進歩と有利な償還政策が市場拡大をさらに刺激しているが、特に新興市場では厳しい規制や高コストといった課題が根強く残っています。注目すべき動向としては、薬物コーティングバルーンや生体吸収性ステントの開発、患者の転帰を最適化し治療へのアドヒアランスを向上させることを目的とした個別化医療やデジタルヘルスソリューションの重視の高まりなどが挙げられます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢
• 特許分析

末梢血管デバイス市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 末梢ステント
• PTAバルーン
• 塞栓保護デバイス
• 大動脈ステント
• 人工外科用移植片
• 慢性完全閉塞デバイス
• その他

末梢血管デバイス市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 末梢動脈疾患（PAD）
• 動脈瘤
• 静脈疾患

末梢血管デバイス市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• 病院
• 外来手術センター（ASC）
• 専門クリニック
• その他

末梢血管デバイス市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Medtronic plc（USA）
• Boston Scientific Corporation（USA）
• Abbott Laboratories（USA）
• Becton, Dickinson and Company（USA）
• Koninklijke Philips N.V.（Netherlands）
• Cook Medical Inc.（USA）
• Terumo Corporation（Japan）
• Cardinal Health, Inc.（USA）
• B. Braun Melsungen AG（Germany）
• BIOTRONIK SE & Co. KG（Germany）
• W. L. Gore & Associates, Inc.（USA）
• Getinge AB（Sweden）
• MicroPort Scientific Corporation（China）
• CryoLife, Inc.（USA）
• Lombard Medical（UK）
• Merit Medical Systems, Inc.（USA）
• Edwards Lifesciences Corporation（USA）
• Nipro Corporation（Japan）
• Bluesail Medical Co., Ltd.（China）

結論と提言

Peripheral Vascular Devices Market size was valued at USD 8.49 billion in 2023 and is poised to grow from USD 8.96 billion in 2024 to USD 13.75 billion by 2032, growing at a CAGR of 5.5% during the forecast period (2025-2032).

The global Peripheral Vascular Devices Market is experiencing significant growth driven by the rising incidence of vascular diseases and an aging population. Increasing lifestyle-related conditions such as diabetes and obesity contribute to this trend, boosting the demand for innovative treatment solutions. These devices facilitate minimally invasive interventions like angioplasty and stenting, which enhance patient comfort and reduce recovery times. Advancements in imaging technologies and favorable reimbursement policies further stimulate market expansion, though challenges such as stringent regulations and high costs persist, particularly in emerging markets. Notable trends include the development of drug-coated balloons and bioresorbable stents, alongside a growing emphasis on personalized medicine and digital health solutions, which aim to optimize patient outcomes and improve adherence to treatment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Vascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Vascular Devices Market Segments Analysis

Global Peripheral Vascular Devices Market is segmented by Type, Application, End-Use and region. Based on Type, the market is segmented into Peripheral Stents, PTA Balloons,embolic protection devices, Aortic Stents, Synthetic Surgical Grafts, Chronic Total Occlusion Devices and Others. Based on Application, the market is segmented into Peripheral Arterial Disease (PAD), Aneurysms and Venous Diseases. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Peripheral Vascular Devices Market

The peripheral vascular devices market is significantly influenced by the escalating incidence of cardiovascular conditions, including peripheral artery disease (PAD) and deep vein thrombosis (DVT). As reported by the World Health Organization (WHO), cardiovascular diseases rank as the primary cause of mortality globally. This rising prevalence not only underscores the urgent need for effective diagnostic and treatment solutions but also fosters an expanding demand for peripheral vascular devices. The ongoing health challenges presented by these conditions are driving advancements and innovations in this market, highlighting its critical role in enhancing patient outcomes and managing cardiovascular health.

Restraints in the Peripheral Vascular Devices Market

One of the major constraints facing the peripheral vascular devices market is the substantial cost linked to these products. The expenses stem from various factors, including extensive research and development expenditures, stringent regulatory compliance, and the incorporation of advanced materials and technologies. These high price tags can hinder the widespread adoption of these devices, especially in developing nations where healthcare budgets are constrained and reimbursement systems often pose challenges. Consequently, the financial burden associated with peripheral vascular devices may restrict their accessibility and utilization, limiting the market's growth potential.

Market Trends of the Peripheral Vascular Devices Market

The peripheral vascular devices market is witnessing a significant shift towards drug-eluting devices, reflecting a heightened demand for innovations that enhance patient outcomes. These advanced devices deliver targeted therapeutic agents directly to affected blood vessels, effectively mitigating the risk of restenosis and minimizing the necessity for repeated interventions. By utilizing drug-eluting stents that disperse anti-proliferative medications, this market trend not only improves long-term efficacy for patients but also aligns with the broader healthcare focus on personalized treatment approaches. As healthcare providers prioritize strategies that optimize recovery and reduce healthcare costs, the adoption of drug-eluting technologies is expected to accelerate in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Peripheral Vascular Devices Market Size by Type & CAGR (2025-2032)

• Market Overview
• Peripheral Stents
• PTA Balloons
• Embolic Protection Devices
• Aortic Stents
• Synthetic Surgical Grafts
• Chronic Total Occlusion Devices
• Others

Global Peripheral Vascular Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Peripheral Arterial Disease (PAD)
• Aneurysms
• Venous Diseases

Global Peripheral Vascular Devices Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Others

Global Peripheral Vascular Devices Market Size & CAGR (2025-2032)

• North America (Type, Application, End-Use)
  • US
  • Canada
• Europe (Type, Application, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lombard Medical (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bluesail Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations